INTRODUCTION
Antioxidants are molecules that inhibit oxidation which under certain conditions leads to the production of free radicals, highly reactive species characterized by an unpaired electron which enter into further chain reactions that lead to cell damage.
(1) In biological systems these include reactive oxygen species (ROS) which include the hydroxyl radical (OH.), hydrogen peroxide (H2O2) and the superoxide anion (O2.-) among others. The generation of such species may trigger a variety of pathological responses and any disequilibrium between production of ROS and the ability to attenuate the damage that such species may incur is referred to as oxidative stress. Oxidative stress may result in damage to any component of the cell and may result in DNA damage through base damage as well as strand breaks and also some ROS may act as cellular messengers causing disruption in cellular signaling. Cellular protection against oxidative stress may be through chelation of trace metals involved in free radical generation or through the actions of antioxidants. Antioxidants are broadly classified into two groups, depending on whether they are soluble in water (hydrophilic), such as vitamin C or fat soluble such as Vitamin E (lipophilic). Hydrophilic antioxidants are thought to predominantly react with oxidants in the cell cytosol and plasma whereas lipophilic antioxidants protect cell membranes from oxidation: a process termed lipid peroxidation. (2) The synergism between different antioxidant systems is complex. Indeed, both vitamin C and vitamin E were shown to have a direct interaction with vitamin C "repairing" the α-tocopherol radical with rates approaching diffusion limited outlining the reactivity of these species. (3) One of the areas that has attracted considerable interest with regard to the role of oxidative stress is the host response to sepsis. (4) Sepsis remains a major cause of death worldwide affecting over 18 million people annually with a mortality rate approaching 80% in those individuals with multi-organ failure and in the US hospital costs total over $24 billion dollars. (5, 6) Therapy for severe sepsis is predominantly supportive with the relatively recent introduction of care bundles including antibiotic therapy being introduced. However, the precise pathogenesis of sepsis-induced organ failure remains elusive and although likely multifactorial in nature certainly microvascular dysfunction appears to be central to the process. (7) Microvascular dysfunction involves impairment of arteriolar reactivity, derangement of endothelial barrier integrity and microthombi induced plugging of the capillaries thus any therapy that addresses these issues may translate into improved outcomes.
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THE CASE FOR ANTIOXIDANT SUP-PLEMENTATION?
Given the putative role of oxidative stress in the pathogenesis of sepsis it follows that antioxidant supplementation may be of potential benefit. Numerous candidate molecules exist but the most studied is that of ascorbic acid (Vitamin C). The almost ubiquitous nature of ascorbic acid throughout the animal kingdom is of interest not least because only humans and guinea pigs fail to synthesize it due to a lack of the enzyme L-Gulonolactone Oxidase which catalyzes the conversion of L-Gulonolactone to L-Ascorbic acid therefore it is only obtained through diet. Ascorbic acid is vital for numerous cellular processes as outlined in Table 1 . The pivotal role for vitamin C is in its antioxidant capacity as outlined in Figure 1 . Certainly preclinical studies have demonstrated that high-dose ascorbate administration can prevent or restore microcirculatory flow impairment through inhibition of nicotinamide adenine dinucleotide phosphateoxidase as well as inducible nitric oxide synthase, augmenting tetrahydrobiopterin. This may prevent uncoupling of oxidative phosphorylation leading to a potential reduction in ROS including superoxide and peroxynitrite. Moreover, vascular responsiveness to vasoconstrictors may be restored through vitamin C administration and also it may preserve the endothelial barrier through preventing apoptosis. Fur- thermore it has been proposed that highdose vitamin C may augment the host response against infection such as protection against overwhelming oxidative stress due to ischemia/reperfusion, sepsis or burns. This may of course be in combination with other antioxidants. (8) Many questions remain unanswered with regard to the role of antioxidant supplementation in sepsis. What is clear, however, is that several studies have shown that sepsis depletes endogenous plasma ascorbate which is not corrected by parenteral nutrition containing a moderate amount of ascorbate (200 mg/day). Levels do return to normal upon resolution of the inflammatory illness which may reflect accelerated destruction of ascorbate. (9) Interestingly, parenteral supplementation may restore plasma ascorbate levels in critically ill patients if the administered dose is adequate. For example, parenteral ascorbate at a dose of 300 mg/day fails, but 1000 mg/ day can be effective. (10) However, the response to vitamin C repletion is somewhat variable in our critically ill patients. After injection of a mixture of antioxidants containing a nominal dose of 1000 mg ascorbate serial blood sampling demonstrated a raised plasma ascorbate in some individuals but not in others. (11) 
RECENT EVIDENCE
A recent study has regenerated interest in the use of ascorbic acid in the critically ill particularly in sepsis following publication of a before-after study. (15) Patients were considered to have sepsis coupled with a procalcitonin level of >2 ng/ml underwent treatment. Patients were treated with a combination of thiamine 200mg iv 12 hourly, as well as 6 hourly ascorbic acid 1.5 G and hydrocortisone 50 mg. 47 patients were in each group which, although not randomized, were well matched in terms of illness severity. Around 50% of each group were mechanically ventilated, 46% on vasopressors, over 60% had evidence of renal dysfunction and approaching 30% had positive blood cultures. The primary endpoint was mortality. Data was analysed using logistic multivariate analysis and also propensity adjusted outcomes. Regardless of statistical model the outcome was the same: a dramatic reduction in mortality in those receiving the vitamin "cocktail" (p<0.001). Moreover, the predicted mortality in the control group was as expected from APACHE IV data of 40% whereas that in the treated group was 10%. Furthermore the rate of renal replacement therapy fell from 33 to 10% in the treatment group. As the authors point out "No patient in the treatment group developed progressive organ failure and the four deaths in this group were related to the patients underlying disease; these patients did not die from sepsis related complications". An astonishing observation.
Clearly this study has several limitations. It is single centre and adopts a before/after non-blinded design and as such will be open to the usual statistical criticisms. It also examined three simultaneous interventions and as therefore ascribing benefit to one particular agent is impossible. However the effect is dramatic especially as studies to-date have not showed any near such response from any of the single agents. Is there evidence that patients with sepsis treated with Thiamine 200mg iv 12 hourly show a 30% fall in observed mortality when used in isolation ? No there is not. Is there evidence that patients with sepsis treated with 6 hourly Ascorbic acid 1.5 G show a 30% fall in observed mortality when used in isolation ? No there is not. And hydrocortisone 50 mg. Any evidence of a 30% fall in observed mortality when used in isolation ? No there despite the numerous sepsis trials. So why should such synergy exist and is it biologically plausible?
BIOLOGICAL PLAUSIBILITY
The combination of ascorbate plus steroid was used as they are considered synergistic particularly in terms of endothelial integrity. However it seems implausible that such a dramatic effect is seen when each component in isolation has little or no effect on outcomes in sepsis. The explanation as to why this combination appeared to have a marked effect on the course of sepsis is proposed to be related to the multiple and overlapping effects of all three agents with vitamin C and corticosteroids acting synergistically. (16 
THE FUTURE?
Despite their being many proponents of vitamin C therapy several questions remain to be solved, including optimal dose, timing and combination of vitamin C with other antioxidants. (8, 22) High-dose vitamin C is cheap and relatively well tolerated. The study by Marik, no matter what one thinks of the results, will no doubt stimulate much debate and the only robust rebuttal will be data from a multi-centre randomized controlled trial. Of course, if this is negative we will then be faced with the argument that it may be centre specific! It does seem implausible that such a dramatic effect will be replicated however we will have to wait and see. In the meantime will you be supplementing your patients antioxidants?
